stockrow
Friday 6 November 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
51.49
0.46
−0.89%
Follow HTFL
Alert me
Heartflow, Inc. (HTFL) EPS (diluted)
Heartflow, Inc.'s EPS (diluted) for fiscal 2025 was −$3.17, compared with −$17.98 in fiscal 2024. Over the twelve months to 30 June 2026 it was −$1.83. Heartflow, Inc. ranks 31st of 42 Health Information Services companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$3.17 | — |
| FY2024 | −$17.98 | — |
| FY2023 | −$25.32 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | −$0.18 | — |
| Mar 2026 | −$0.32 | — |
| Dec 2025 | −$0.29 | — |
| Sep 2025 | −$1.04 | — |
| 6 more quarters | Free account |
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| HQY HealthEquity, Inc. compare | $2.77 |
| HNGE Hinge Health Inc. compare | $1.28 |
| OMCL Omnicell, Inc. compare | $0.96 |
| DOCS Doximity, Inc. compare | $0.72 |
| WAY Waystar Holding Corp. compare | $0.69 |
| PRVA Privia Health Group, Inc. compare | $0.27 |
| SDGR Schrodinger, Inc. compare | −$0.79 |
| TDOC Teladoc Health, Inc. compare | −$0.86 |
| HTFL Heartflow, Inc. | −$1.83 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on HTFL
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement